IHVR-17028

CAS No. 1428247-78-2

IHVR-17028( —— )

Catalog No. M35076 CAS No. 1428247-78-2

IHVR-17028 is a potent broad-spectrum ERα-glucosidase I (α-glucosidase? I) inhibitor with IC50 of 0.24 μM and antiviral activity. IHVR-17028 inhibited BVDV, TCRV and DENV, and EC50 values were 0.4 μM, 0.26 μM and 0.3 μM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 451 Get Quote
5MG 653 Get Quote
10MG 905 Get Quote
25MG 1334 Get Quote
50MG 1674 Get Quote
100MG 2052 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    IHVR-17028
  • Note
    Research use only, not for human use.
  • Brief Description
    IHVR-17028 is a potent broad-spectrum ERα-glucosidase I (α-glucosidase? I) inhibitor with IC50 of 0.24 μM and antiviral activity. IHVR-17028 inhibited BVDV, TCRV and DENV, and EC50 values were 0.4 μM, 0.26 μM and 0.3 μM, respectively.
  • Description
    IHVR-17028 is a potent and broad-spectrum antiviral agent. IHVR-17028 exhibits antiviral activity against BVDV, TCRV and DENV with EC50 values of 0.4 μM, 0.26 μM, 0.3 μM, respectively. IHVR-17028 is a potent ER α-glucosidase?I?inhibitor with an IC50 of 0.24 μM. IHVR-17028 can be used for infectious diseases research.
  • In Vitro
    In virus yield reduction assays, IHVR-17028 inhibits viral activities with EC50 values of 0.4 μM, 0.26 μM, 0.3 μM for bovine viral diarrhea virus (BVDV) (NADL strain), tacaribe virus (TCRV) (11573 strain), DENV (serotype 2, New Guinea C), respectively. And in MTT assays, IHVR-17028 exhibits IC50 values of all >500 μM inMDBK, Huh7.5 or BHK cells.
  • In Vivo
    In Pharmacokinetic analysis in rats, IHVR17028 (oral gavage; 75 mg/kg) shows a Cmax?value of 0.18 μg/ml; the Tmax value is 1.56 hours; and the F% value is 12% after PO administration, the T1/2 value is 0.88 hour after iv. adminstration.IHVR-17028 (oral gavage; 25-50 mg/kg; treatment 1 day prior to virus challenging) exhibits significant protection in mouse model of lethal MARV infection.Animal Model:BALB/c mice are challenged with 1,000 PFU mouse adapted MARV via IP injection Dosage:50 mg/kg Administration:Treatment 1 day prior to virus challenging Result:Exhibited protection in mouse when the treatment is initiated 1 day prior to virus challenging.Animal Model:C57B1/6 mice challenged with 1,000 PFU mouse adapted EBOV Dosage:25 mg/kg Administration:Twice daily at 12 h interval; starting 4 h post infection for 10 days Result:Inhibited EBOV infection in mice.
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Influenza Virus
  • Recptor
    Influenza Virus | Glucosidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1428247-78-2
  • Formula Weight
    428.61
  • Molecular Formula
    C23H44N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCCCCN(C(C(C)(C)C)=O)C1CCCCC1)N2[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jinhong Chang, et al. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.Antiviral Res. 2013 Jun;98(3):432-40.?
molnova catalog
related products
  • LYS01

    LYS01 free base is a new lysosomal autophagy inhibitor.

  • LJ 001

    LJ 001 ((LJ-001, LJ001)?is a broad-spectrum antiviral agent targeting entry of enveloped viruses.

  • CEF7, Influenza Viru...

    HLA-B*08 restricted influenza virus nucleoprotein epitope.